Psilocybin-Assisted Therapy for Intergenerational Trauma

Summary

This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.

Timeline

Start

2025-08-28

Primary completion

2029-05-31

Completion

2030-01-02

Drugs

Indications